Indian Government Rejects WHO Definition Of Counterfeit Drugs; Stresses Need For Harmonization Among Member States
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The Indian government may have succeeded in blocking a move to redefine "counterfeit drugs" by the International Medical Products Anti-Counterfeiting Taskforce - an arm of the World Health Organization. In its definition, IMPACT defined a medical product as counterfeit "when there is a false representation in relation to its identity, history or source.
You may also be interested in...
India Says Counterfeit Drugs Should Be Handled By WTO - Not WHO
MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs
India Says Counterfeit Drugs Should Be Handled By WTO - Not WHO
MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs
Roche India's Efforts To Curb Fake Drugs Gain Popularity
NEW DELHI - While the global pharmaceutical industry struggles to arrive at a consensus on a new definition of counterfeit drugs, pharmaceutical company Roche India has introduced a cost-effective technology to tackle the problem called 'mass serialisation' that is fast gaining popularity among customers, say company officials